test

Derek Gould

@Logos Global Management Lp

Latest period2024 - Q3ReportedManaged Assets$926.849MTotal holdings55
Assets growth rate-62.55%Assets growth rate (2-Q avg)18.89%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Logos Global Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Logos Global Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 926.849M in assets, with a quarterly growth rate of -62.55% and a 2-quarter average growth rate of 18.89%. The portfolio is managed by Derek Gould, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IDYAIdeaya Biosciences Inc
Recent Activity
Decreased -38.23%
7.18%
$66.528M
2.1M shares@ $31.68 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Decreased -59.67%
5.92%
$54.863M
1.25M shares@ $43.89 avg price
RVMDRevolution Medicines Inc
Recent Activity
Decreased -50%
5.88%
$54.42M
1.2M shares@ $45.35 avg price
IRONDisc Medicine Inc
Recent Activity
Decreased -49.45%
4.96%
$45.946M
935,000 shares@ $49.14 avg price
JANXJanux Therapeutics Inc
Recent Activity
Decreased -33.33%
4.91%
$45.43M
1M shares@ $45.43 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Decreased -50%
4.14%
$38.314M
3.209M shares@ $11.95 avg price
PCVXVaxcyte Inc
Recent Activity
New Position
3.7%
$34.281M
300,000 shares@ $114.27 avg price
IMVTImmunovant Inc
Recent Activity
Decreased -4.34%
3.39%
$31.361M
1.1M shares@ $28.51 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
New Position
3.31%
$30.591M
900,000 shares@ $33.99 avg price
OCULOcular Therapeutix Inc
Recent Activity
Decreased -66.01%
3.29%
$30.45M
3.5M shares@ $8.7 avg price